Nephros (NEPH) EBT Margin Growth (1y) (2011 - 2026)
Nephros (NEPH) EBT Margin Growth (1y) (2011 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 126.32 Bn | 121.10 Bn | 1.96 Bn | 236.00 |
| 2 | Becton Dickinson | 44.69 Bn | 43.88 Bn | 2.15 Bn | -366.00 |
| 3 | Alcon | 32.80 Bn | 31.14 Bn | 1.53 Bn | - |
| 4 | Medline | 32.72 Bn | 30.49 Bn | 1.84 Bn | -113.00 |
| 5 | Resmed | 29.54 Bn | 27.88 Bn | 890.98 Mn | 276.00 |
| 6 | West Pharmaceutical Services | 23.56 Bn | 23.13 Bn | 329.20 Mn | 16.00 |
| 7 | Solventum | 14.00 Bn | 13.44 Bn | 1.10 Bn | -104.00 |
| 8 | Cooper Companies | 13.75 Bn | 13.61 Bn | 735.40 Mn | -1,889.00 |
| 9 | Align Technology | 12.03 Bn | 10.97 Bn | 736.59 Mn | -3.00 |
| 10 | Nephros | 36.20 Mn | 32.18 Mn | 2.99 Mn | 1,899.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,899.00 |
| Dec 31, 2025 | -809.00 |
| Sep 30, 2025 | 194.00 |
| Jun 30, 2025 | 1,445.00 |
| Mar 31, 2025 | -1,253.00 |
| Dec 31, 2024 | 2,293.00 |
| Sep 30, 2024 | 3,281.00 |
| Jun 30, 2024 | 776.00 |
| Mar 31, 2024 | 659.00 |
| Dec 31, 2023 | 1,341.00 |
| Sep 30, 2023 | 4,383.00 |
| Jun 30, 2023 | 1,687.00 |
| Mar 31, 2023 | 6,564.00 |
| Dec 31, 2022 | -18.00 |
| Sep 30, 2022 | -3,719.00 |
| Jun 30, 2022 | 1,742.00 |
| Mar 31, 2022 | -4,056.00 |
| Dec 31, 2021 | 447.00 |
| Sep 30, 2021 | 1,106.00 |
| Jun 30, 2021 | 5,218.00 |